132 related articles for article (PubMed ID: 15097224)
1. Tranilast and hypertensive heart disease: further insights into mechanisms of an anti-inflammatory and anti-fibrotic drug.
Pfab T; Hocher B
J Hypertens; 2004 May; 22(5):883-6. PubMed ID: 15097224
[No Abstract] [Full Text] [Related]
2. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats.
Kagitani S; Ueno H; Hirade S; Takahashi T; Takata M; Inoue H
J Hypertens; 2004 May; 22(5):1007-15. PubMed ID: 15097242
[TBL] [Abstract][Full Text] [Related]
3. Granulomatous blepharitis successfully treated with tranilast.
Iwao F; Sawamura D; Yokota K; Shimizu H
Br J Dermatol; 2003 Jul; 149(1):222-4. PubMed ID: 12890236
[No Abstract] [Full Text] [Related]
4. [A case of colonic Crohn's disease possibly managed with tranilast].
Kikuchi T; Okazaki M; Osada T; Itoh J
Nihon Shokakibyo Gakkai Zasshi; 1997 Mar; 94(3):195-9. PubMed ID: 9095639
[No Abstract] [Full Text] [Related]
5. Inhibition of neointima formation by tranilast in pig coronary arteries after balloon angioplasty and stent implantation.
Ishiwata S; Verheye S; Robinson KA; Salame MY; de Leon H; King SB; Chronos NA
J Am Coll Cardiol; 2000 Apr; 35(5):1331-7. PubMed ID: 10758977
[TBL] [Abstract][Full Text] [Related]
6. Disseminated granulomatous skin lesions associated with myelodysplastic syndrome treated successfully with tranilast: a case report and review of the literature.
Yoneta K; Fujimoto N; Teramura K; Takayama S; Tanaka T
Eur J Dermatol; 2016 Aug; 26(4):398-400. PubMed ID: 27229541
[No Abstract] [Full Text] [Related]
7. Treatment of granuloma annulare with tranilast.
Yamada H; Ide A; Sugiura M; Kurihara S; Tajima S
J Dermatol; 1995 May; 22(5):354-6. PubMed ID: 7545709
[TBL] [Abstract][Full Text] [Related]
8. Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.
Mifsud S; Kelly DJ; Qi W; Zhang Y; Pollock CA; Wilkinson-Berka JL; Gilbert RE
Nephron Physiol; 2003; 95(4):p83-91. PubMed ID: 14694265
[TBL] [Abstract][Full Text] [Related]
9. Recurrent epithelioid hemangioma: therapeutic potential of tranilast and indomethacin.
Ogura K; Shinoda Y; Okuma T; Ushiku T; Motoi T; Kawano H
J Orthop Sci; 2012 Mar; 17(2):194-8. PubMed ID: 21559957
[No Abstract] [Full Text] [Related]
10. Tranilast inhibits transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation.
Saiura A; Sata M; Hirata Y; Nagai R; Makuuchi M
Eur J Pharmacol; 2001 Dec; 433(2-3):163-8. PubMed ID: 11755148
[TBL] [Abstract][Full Text] [Related]
11. Possible antistenotic effect of tranilast in a patient with small bowel tuberculosis to prevent intestinal obstruction due to stenosis progression by antituberculous chemotherapy.
Oshitani N; Takeda S; Matsumoto H; Minamino H; Hayakawa T; Aomatsu K
Dig Endosc; 2013 May; 25(3):333-5. PubMed ID: 23363021
[TBL] [Abstract][Full Text] [Related]
12. The impact of tranilast on restenosis after coronary angioplasty: the Second Tranilast Restenosis Following Angioplasty Trial (TREAT-2).
Tamai H; Katoh K; Yamaguchi T; Hayakawa H; Kanmatsuse K; Haze K; Aizawa T; Nakanishi S; Suzuki S; Suzuki T; Takase S; Nishikawa H; Katoh O
Am Heart J; 2002 Mar; 143(3):506-13. PubMed ID: 11868058
[TBL] [Abstract][Full Text] [Related]
13. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.
Zhang Y; Edgley AJ; Cox AJ; Powell AK; Wang B; Kompa AR; Stapleton DI; Zammit SC; Williams SJ; Krum H; Gilbert RE; Kelly DJ
Eur J Heart Fail; 2012 May; 14(5):549-62. PubMed ID: 22417655
[TBL] [Abstract][Full Text] [Related]
14. Acute suppression of TGF-ß with local, sustained release of tranilast against the formation of fibrous capsules around silicone implants.
Park S; Park M; Kim BH; Lee JE; Park HJ; Lee SH; Park CG; Kim MH; Kim R; Kim EH; Heo CY; Choy YB
J Control Release; 2015 Feb; 200():125-37. PubMed ID: 25528612
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension.
Hocher B; Godes M; Olivier J; Weil J; Eschenhagen T; Slowinski T; Neumayer HH; Bauer C; Paul M; Pinto YM
J Hypertens; 2002 Apr; 20(4):745-51. PubMed ID: 11910312
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of tolfenamic acid.
Corell T
Pharmacol Toxicol; 1994; 75 Suppl 2():14-21. PubMed ID: 7816775
[No Abstract] [Full Text] [Related]
17. Control of pain by nonsteroidal anti-inflammatory drugs.
Kantor TG
Med Clin North Am; 1982 Sep; 66(5):1053-9. PubMed ID: 6982381
[No Abstract] [Full Text] [Related]
18. Selecting an appropriate NSAID.
Foley JJ; Warfield CA
Hosp Pract (Off Ed); 1987 Apr; 22(4):54-6. PubMed ID: 3104368
[No Abstract] [Full Text] [Related]
19. Suppressive effects of tranilast on pulmonary fibrosis and activation of alveolar macrophages in mice treated with bleomycin: role of alveolar macrophages in the fibrosis.
Mori H; Tanaka H; Kawada K; Nagai H; Koda A
Jpn J Pharmacol; 1995 Apr; 67(4):279-89. PubMed ID: 7544418
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cutaneous sarcoidosis with tranilast.
Yamada H; Ide A; Sugiura M; Tajima S
J Dermatol; 1995 Feb; 22(2):149-52. PubMed ID: 7536763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
